BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹14,069 Cr | ₹14,334 Cr | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr |
What is the latest Total Current Liabilities ratio of BIOCON ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹14,069 Cr |
| Mar2025 | ₹14,334 Cr |
| Mar2024 | ₹15,359 Cr |
| Mar2023 | ₹8,511 Cr |
| Mar2022 | ₹3,828 Cr |
How is Total Current Liabilities of BIOCON Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹14,069 Cr | -1.85 | |
| Mar2025 | ₹14,334 Cr | -6.67 | |
| Mar2024 | ₹15,359 Cr | 80.46 | |
| Mar2023 | ₹8,511 Cr | 122.33 | |
| Mar2022 | ₹3,828 Cr | - | |
Compare Total Current Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,518.5 Cr | -0.4% | -5.9% | 17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -0.4% |
-5.9% |
17.8% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses